Evidence map›Paper›PMID 24319095›Full record

ArticleCirculation. Heart failure2014

Deep sequence analysis of gene expression identifies osteopontin as a downstream effector of integrin-linked kinase (ILK) in cardiac-specific ILK knockout mice.

Jing Dai, Takashi Matsui, E Dale Abel, Shoukat Dedhar, Robert E Gerszten, Christine E Seidman, J G Seidman, Anthony Rosenzweig

Open access · bronzeAbstract read
In one paragraph

Article in Circulation. Heart failure, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Jing DaiCardiovascular Division, Beth Israel Deaconess Medical Center, Boston, MA.
Takashi Matsui
E Dale Abel
Shoukat Dedhar
Robert E Gerszten
Christine E Seidman
J G Seidman
Anthony Rosenzweig
Brigham and Women's Hospital · USHarvard University · USUniversity of Utah · USMassachusetts General Hospital · USUniversity of Hawaiʻi at Mānoa · US

Funding

Translational Research Skills Development CoreU54HL112311 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S, ZIMMERMAN, GUY A. · 2012 to 2016
$12.9M
Defining Pathways from Gene Mutation to Heart FailureR01HL080494 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI CHEN, CHRISTOPHER S, SEIDMAN, CHRISTINE E · 2005 to 2024
$9.4M
Training Program in Cardiovascular ResearchT32HL007374 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI MITTLEMAN, MURRAY A · 1985 to 2019
$7.9M
Molecular Signaling in Hypertrophic CardiomyopathyR01HL084553 · NHLBI · HARVARD MEDICAL SCHOOL · PI SEIDMAN, JONATHAN G · 2007 to 2022
$5.9M
Role of Integrin-Linked Kinase in Heart Failure and Ischemic InjuryR01HL059521 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENZWEIG, ANTHONY · 1998 to 2010
$3.7M
Role of serum- and glucocorticoid-regulated kinase-1 in electrical remodelingR01HL094677 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ROSENZWEIG, ANTHONY · 2010 to 2013
$1.7M
Role of mTOR in the diabetic heartR01HL098423 · NHLBI · UNIVERSITY OF HAWAII AT MANOA · PI MATSUI, TAKASHI · 2010 to 2013
$1.5M
CIHRNHLBI NIH HHS HL059521NHLBI NIH HHS HL094677NHLBI NIH HHS HL098423NHLBI NIH HHS R01 HL059521NHLBI NIH HHS R01 HL080494NHLBI NIH HHS R01 HL084553NHLBI NIH HHS R01 HL094677NHLBI NIH HHS R01 HL098423NHLBI NIH HHS T32 HL007374NHLBI NIH HHS T32 HL073734NHLBI NIH HHS U54 HL112311
6 · The paper itself

Abstract

backgroundIntegrin-linked kinase (ILK) is a serine/threonine kinase that has been linked to human and experimental heart failure, but its role in the heart is not fully understood. METHODS AND

resultsTo define the role of cardiomyocyte ILK, we generated cardiac-specific ILK knockout mice using α-myosin heavy chain-driven Cre expression. Cardiac-specific ILK knockout mice spontaneously developed lethal dilated cardiomyopathy and heart failure with an early increase in apoptosis, fibrosis, and cardiac inflammation. To identify downstream effectors, we used deep sequence analysis of gene expression to compare comprehensive transcriptional profiles of cardiac-specific ILK knockout and wild-type hearts from 10-day-old mice before the development of cardiac dysfunction. Approximately 2×10(6) cDNA clones from each genotype were sequenced, corresponding to 33 274 independent transcripts. A total of 93 genes were altered, using nominal thresholds of >1.4-fold change and P<0.001. The most highly upregulated gene was osteopontin (47-fold increase; P=9.6×10(-45)), an inflammatory chemokine implicated in heart failure pathophysiology. ILK also regulated osteopontin expression in cardiomyocytes in vitro. Importantly, blocking antibodies to osteopontin mitigated but did not fully rescue the functional decline in cardiac-specific ILK knockout mice.

conclusionsCardiomyocyte-specific ILK deletion leads to a lethal cardiomyopathy characterized by cardiomyocyte death, fibrosis, and inflammation. Comprehensive profiling identifies ILK-dependent transcriptional effects and implicates osteopontin as a contributor to these phenotypes.

Indexed as

High-Throughput Nucleotide SequencingTranscriptomeAnimalsAntibodiesApoptosisCardiomyopathy, DilatedDisease Models, AnimalFemaleGenotypeHeart FailureMaleMiceMice, Inbred C57BLMice, KnockoutMyocytes, CardiacNecrosisAntibodiesOsteopontinProtein Serine-Threonine KinasesScaffold Protein ILKcardiomyopathy, dilatedgene expression profilingintegrin-linked kinaseosteopontin

Identifiers

PMID24319095
PMCPMC3950354
OpenAlexW2546595470

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.